Showing results (281-290 of 487) with videos related to
Sort By:
Pageof 49
JOP : Journal of the Pancreas|July 9, 2011
Novel agents for the treatment of pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Haiying Cheng, Eirini Merika, Kostas N Syrigos, et al.Clinical Colorectal Cancer|January 7, 2011
Safety and efficacy of panitumumab therapy after progression with cetuximab: experience at two institutionsMuhammad Wasif Saif, Kristin Kaley, Edward Chu, et al.JOP : Journal of the Pancreas|July 6, 2010
Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Jia Li, Man Yee Merl, John Chabot, et al.JOP : Journal of the Pancreas|July 6, 2010
First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Man Yee Merl, Osama Abdelghany, Jia Li, et al.Cancer Medicine Journal|February 26, 2021
Retrospective Analysis of Patients with Gynecological Uterine Sarcomas: Leiomyosarcomas and other Histological Subtypes at a Single Institution from 1996 to 2015Olger Nano, Maria J Nieto, Muhammad Wasif Saif, et al.JOP : Journal of the Pancreas|July 13, 2013
Biomarkers in neuroendocrine tumorsMarvin Duque, Irvin M Modlin, Anumeha Gupta, et al.Cancer Chemotherapy and Pharmacology|July 1, 2017
Does "OPTINAB" strategy ("stop-and-go") work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel-gemcitabine?Valerie Relias, Antonia Maloney, Melissa H Smith, et al.JOP : Journal of the Pancreas|January 14, 2014
Gemcitabine as salvage treatment in patients with poorly differentiated pancreatic neuroendocrine tumors: a case seriesMuhammad Wasif Saif, Kristin Kaley, Teresa Rodriguez, et al.Journal of Clinical Haematology|April 9, 2021
Lower 24-Month Relative Survival among Black Patients with Non- Hodgkin's Lymphoma: An Analysis of the SEER Data 1997-2015Maria J Nieto, Zhen Li, Hasan Rehman, et al.JOP : Journal of the Pancreas|July 31, 2014
Chemotherapy and metformin in pancreatic adenocarcinoma and neuroendocrine tumorsSaira Burney, Khadija Irfan Khawaja, Muhammad Wasif Saif, et al.Pageof 49